Compare CXW & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CXW | LMAT |
|---|---|---|
| Founded | 1983 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 1997 | 2006 |
| Metric | CXW | LMAT |
|---|---|---|
| Price | $18.60 | $86.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $34.00 | ★ $101.83 |
| AVG Volume (30 Days) | ★ 917.2K | 136.2K |
| Earning Date | 02-11-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 0.92% |
| EPS Growth | ★ 49.55 | 27.40 |
| EPS | 1.00 | ★ 2.32 |
| Revenue | ★ $2,086,522,000.00 | $240,866,000.00 |
| Revenue This Year | $12.51 | $15.17 |
| Revenue Next Year | $15.41 | $9.07 |
| P/E Ratio | ★ $18.54 | $37.41 |
| Revenue Growth | 5.72 | ★ 13.07 |
| 52 Week Low | $15.95 | $71.42 |
| 52 Week High | $23.54 | $105.55 |
| Indicator | CXW | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 42.12 | 54.17 |
| Support Level | $18.27 | $83.27 |
| Resistance Level | $18.81 | $88.50 |
| Average True Range (ATR) | 0.57 | 2.32 |
| MACD | -0.14 | 0.14 |
| Stochastic Oscillator | 16.93 | 59.66 |
CoreCivic Inc is an owner and operator of private prisons and detention centers in the United States. It operates in three segments: Safety, Community, and Properties. The Community segment owns and operates residential reentry centers. The Properties segment owns properties for lease to third parties and government agencies. The vast majority of the company's revenue comes from the CoreCivic Safety segment which consists of correctional and detention facilities that are owned, or controlled via a long-term lease, and managed by the company, as well as those correctional and detention facilities owned by third parties but managed by CoreCivic.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.